Company Profile
Virax Biolabs Stock Price, News & Analysis
- Ticker:
- VRAX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Virax Biolabs is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Stock performance
0.15 USD (-4.97%)
Close
Last updated: June 23, 2026 at 00:00
3.09M USD
Market cap
Why the stock is moving
VRAX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Virax Biolabs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Virax Biolabs is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Business Model Characteristics
Virax Biolabs is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.
Position Within the Biotechnology Landscape
Compared with therapeutic biotech names, Virax Biolabs sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
Source: Virax Biolabs
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Virax Biolabs (VRAX)?
Virax Biolabs (VRAX) most recently closed at 0.15 USD, a -4.97% move versus the previous session.
What is the market cap of Virax Biolabs (VRAX)?
Virax Biolabs currently has a market capitalization of 3.09M USD on BioPharmSignal.
What does Virax Biolabs do?
Virax Biolabs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
On which exchange is VRAX stock listed?
Virax Biolabs (VRAX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Virax Biolabs is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Biotechnology.
What is Virax?
Virax Biolabs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Which conditions is Virax Biolabs targeting with Virax?
Virax Biolabs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
What is Biolabs?
Virax Biolabs is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.